1 year return (CAGR)
-40.94%
FibroGen Inc Exchange (NASDAQ, USD)
FGEN
-
-0.28 (-2.95%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-71.60%
5 year return (CAGR)
-60.34%
10 year return (CAGR)
-35.69%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
37.30M
Price/Sales
-
Ent value
38.85M
Price/Book
2.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-23.09%
Trailing P/E
0.17
PEG
-
Forward P/E
-
EPS growth
-53.64%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 9.51 |
| Daily high | 9.66 |
| Daily low | 9.22 |
| Daily Volume | 19K |
| 1y analyst estimate | 43.00 |
| Beta | 0.75 |
| EPS (TTM) | 53.33 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FGEN | S&P500 | |
| Current price drop from All-time high | -99.45% | -0.32% |
| Highest price drop | -99.69% | -56.47% |
| Date of highest drop | 18 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -55.23% | -10.68% |
| Avg time to new high | 90 days | 12 days |
| Max time to new high | 1889 days | 1805 days |
News
No items found